Susquehanna International Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $112M | Sell |
381,500
-89,500
| -19% | -$29.4M | 0.01% | 764 |
|
|
2025
Q4 | $165M | Sell |
471,000
-105,200
| -18% | -$35.6M | 0.02% | 618 |
|
|
2025
Q3 | $186M | Buy |
576,200
+333,600
| +138% | +$104M | 0.02% | 567 |
|
|
2025
Q2 | $94.4M | Sell |
242,600
-49,400
| -17% | -$19.9M | 0.01% | 789 |
|
|
2025
Q1 | $127M | Sell |
292,000
-5,300
| -2% | -$2.13M | 0.02% | 550 |
|
|
2024
Q4 | $110M | Buy |
297,300
+7,400
| +3% | +$3.1M | 0.02% | 658 |
|
|
2024
Q3 | $151M | Sell |
289,900
-106,600
| -27% | -$56.9M | 0.03% | 482 |
|
|
2024
Q2 | $215M | Buy |
396,500
+94,200
| +31% | +$49.8M | 0.04% | 337 |
|
|
2024
Q1 | $157M | Buy |
302,300
+31,600
| +12% | +$15.7M | 0.03% | 482 |
|
|
2023
Q4 | $128M | Sell |
270,700
-55,600
| -17% | -$25.7M | 0.02% | 566 |
|
|
2023
Q3 | $142M | Sell |
326,300
-14,500
| -4% | -$6.58M | 0.03% | 468 |
|
|
2023
Q2 | $151M | Buy |
340,800
+1,300
| +0.4% | +$600K | 0.03% | 440 |
|
|
2023
Q1 | $156M | Buy |
339,500
+33,300
| +11% | +$15.8M | 0.03% | 436 |
|
|
2022
Q4 | $157M | Sell |
306,200
-67,900
| -18% | -$34.5M | 0.04% | 398 |
|
|
2022
Q3 | $170M | Buy |
374,100
+107,800
| +40% | +$51.6M | 0.04% | 347 |
|
|
2022
Q2 | $129M | Sell |
266,300
-44,700
| -14% | -$22.1M | 0.03% | 435 |
|
|
2022
Q1 | $153M | Sell |
311,000
-43,400
| -12% | -$19.8M | 0.03% | 490 |
|
|
2021
Q4 | $164M | Sell |
354,400
-301,500
| -46% | -$127M | 0.02% | 521 |
|
|
2021
Q3 | $245M | Buy |
655,900
+133,400
| +26% | +$50.7M | 0.03% | 439 |
|
|
2021
Q2 | $199M | Sell |
522,500
-235,600
| -31% | -$90M | 0.03% | 500 |
|
|
2021
Q1 | $272M | Buy |
758,100
+280,400
| +59% | +$90.2M | 0.04% | 352 |
|
|
2020
Q4 | $153M | Buy |
477,700
+66,700
| +16% | +$20.5M | 0.03% | 502 |
|
|
2020
Q3 | $110M | Sell |
411,000
-83,800
| -17% | -$22.5M | 0.02% | 533 |
|
|
2020
Q2 | $130M | Sell |
494,800
-9,700
| -2% | -$2.59M | 0.03% | 414 |
|
|
2020
Q1 | $115M | Buy |
504,500
+23,500
| +5% | +$6.4M | 0.04% | 345 |
|
|
2019
Q4 | $145M | Buy |
481,000
+124,600
| +35% | +$34.3M | 0.04% | 358 |
|
|
2019
Q3 | $85.6M | Sell |
356,400
-134,200
| -27% | -$36.8M | 0.03% | 503 |
|
|
2019
Q2 | $138M | Buy |
490,600
+38,100
| +8% | +$10.4M | 0.05% | 316 |
|
|
2019
Q1 | $130M | Sell |
452,500
-247,100
| -35% | -$71.5M | 0.05% | 307 |
|
|
2018
Q4 | $184M | Buy |
699,600
+131,600
| +23% | +$36.2M | 0.07% | 232 |
|
|
2018
Q3 | $156M | Sell |
568,000
-92,100
| -14% | -$23.9M | 0.05% | 307 |
|
|
2018
Q2 | $157M | Buy |
660,100
+177,800
| +37% | +$41.2M | 0.05% | 290 |
|
|
2018
Q1 | $106M | Buy |
482,300
+231,100
| +92% | +$54.3M | 0.04% | 368 |
|
|
2017
Q4 | $56.5M | Sell |
251,200
-134,600
| -35% | -$28.7M | 0.02% | 637 |
|
|
2017
Q3 | $73.3M | Buy |
385,800
+190,800
| +98% | +$36.3M | 0.03% | 495 |
|
|
2017
Q2 | $36.7M | Sell |
195,000
-490,500
| -72% | -$88.1M | 0.02% | 764 |
|
|
2017
Q1 | $113M | Buy |
685,500
+261,000
| +61% | +$41.5M | 0.06% | 298 |
|
|
2016
Q4 | $61M | Buy |
424,500
+121,200
| +40% | +$16.2M | 0.03% | 488 |
|
|
2016
Q3 | $38M | Sell |
303,300
-38,800
| -11% | -$5.01M | 0.02% | 656 |
|
|
2016
Q2 | $44.9M | Buy |
342,100
+7,800
| +2% | +$1.07M | 0.02% | 550 |
|
|
2016
Q1 | $46.5M | Buy |
334,300
+47,200
| +16% | +$6.31M | 0.02% | 549 |
|
|
2015
Q4 | $40M | Sell |
287,100
-30,300
| -10% | -$4.17M | 0.02% | 719 |
|
|
2015
Q3 | $44.4M | Buy |
317,400
+10,000
| +3% | +$1.5M | 0.02% | 687 |
|
|
2015
Q2 | $50.5M | Buy |
307,400
+34,400
| +13% | +$5.5M | 0.02% | 688 |
|
|
2015
Q1 | $42.2M | Buy |
273,000
+76,900
| +39% | +$10.9M | 0.02% | 720 |
|
|
2014
Q4 | $24.6M | Sell |
196,100
-128,900
| -40% | -$15.9M | 0.01% | 1188 |
|
|
2014
Q3 | $38.9M | Buy |
325,000
+71,100
| +28% | +$8.16M | 0.02% | 883 |
|
|
2014
Q2 | $27.3M | Sell |
253,900
-110,100
| -30% | -$11.3M | 0.01% | 1122 |
|
|
2014
Q1 | $36.2M | Buy |
364,000
+83,200
| +30% | +$7.52M | 0.02% | 819 |
|
|
2013
Q4 | $25.9M | Sell |
280,800
-438,100
| -61% | -$38.9M | 0.01% | 1113 |
|
|
2013
Q3 | $60.1M | Buy |
718,900
+135,200
| +23% | +$11.6M | 0.03% | 516 |
|
|
2013
Q2 | $47.8M | Buy |
+583,700
| New | +$43.7M | 0.03% | 586 |
|
Other funds holding ELV
VCM
VPM
Susquehanna International Group's ELV Position: Q1 2026 in Review
Susquehanna International Group increased its Elevance Health (ELV) stake by 17% in Q1 2026, buying an estimated $7.29M and bringing the position to 150,529 shares worth $44.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1391.
Susquehanna International Group first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $92.8M in Q2 2023. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Susquehanna International Group held 150,529 shares of Elevance Health worth $44.1M as of Q1 2026.
- Susquehanna International Group bought 22,176 Elevance Health shares in Q1 2026, an estimated $7.29M.
- Elevance Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1391 holding.
- Susquehanna International Group first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
- Susquehanna International Group's Elevance Health position peaked at $92.8M in Q2 2023.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.